Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach.

MLA

Jen, Hsiao-Hsuan, et al. “Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach.” Infectious Diseases and Therapy, vol. 10, no. 2, June 2021, pp. 815–25. EBSCOhost, https://doi.org/10.1007/s40121-021-00431-9.

APA

Jen, H.-H., Chang, W.-J., Lin, T.-Y., Hsu, C.-Y., Yen, A. M.-F., Lai, C.-C., & Chen, T. H.-H. (2021). Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach. Infectious Diseases and Therapy, 10(2), 815–825. https://doi.org/10.1007/s40121-021-00431-9

Chicago

Jen, Hsiao-Hsuan, Wei-Jung Chang, Ting-Yu Lin, Chen-Yang Hsu, Amy Ming-Fang Yen, Chao-Chih Lai, and Tony Hsiu-Hsi Chen. 2021. “Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach.” Infectious Diseases and Therapy 10 (2): 815–25. doi:10.1007/s40121-021-00431-9.